Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.
作者信息
Sörgel Fritz, Malin Jakob J, Hagmann Henning, Kinzig Martina, Bilal Muhammad, Eichenauer Dennis A, Scherf-Clavel Oliver, Simonis Alexander, El Tabei Lobna, Fuhr Uwe, Rybniker Jan
机构信息
IBMP - Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562, Nürnberg-Heroldsberg, Germany.
Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany.
出版信息
J Antimicrob Chemother. 2021 Feb 11;76(3):825-827. doi: 10.1093/jac/dkaa500.
Abstract
摘要
相似文献
1
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.
J Antimicrob Chemother. 2021 Feb 11;76(3):825-827. doi: 10.1093/jac/dkaa500.
2
Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.
Eur J Clin Pharmacol. 2021 Oct;77(10):1583-1585. doi: 10.1007/s00228-021-03128-7. Epub 2021 May 12.
3
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.
J Pharm Pharm Sci. 2021;24:277-291. doi: 10.18433/jpps32011.
4
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.
J Am Soc Nephrol. 2020 Jul;31(7):1384-1386. doi: 10.1681/ASN.2020050589. Epub 2020 Jun 8.
5
Remdesivir use in COVID-19 patients with end-stage kidney disease on intermittent hemodialysis: An absolute contraindication?
Ther Apher Dial. 2022 Aug;26(4):850-851. doi: 10.1111/1744-9987.13833. Epub 2022 Mar 16.
6
Timing of remdesivir for COVID-19.
Med Lett Drugs Ther. 2020 Oct 19;62(1609):161.
7
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.01814-20.
8
Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.
J Med Virol. 2021 Apr;93(4):1860-1861. doi: 10.1002/jmv.26638. Epub 2020 Nov 10.
9
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
JAMA Pediatr. 2020 Oct 1;174(10):e202422. doi: 10.1001/jamapediatrics.2020.2422. Epub 2020 Oct 5.
10
Update Alert 2: Remdesivir for Adults With COVID-19.
Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5.
引用本文的文献
1
Pharmacokinetic simulations for remdesivir and its metabolites in healthy subjects and patients with renal impairment.
Front Pharmacol. 2025 Mar 27;16:1488961. doi: 10.3389/fphar.2025.1488961. eCollection 2025.
2
Impact of Extracorporeal Membrane Oxygenation Circuitry on Remdesivir.
J Pediatr Pharmacol Ther. 2024 Jun;29(3):248-254. doi: 10.5863/1551-6776-29.3.248. Epub 2024 Jun 10.
3
Remdesivir in Patients with Advanced Renal Failure and COVID-19.
Tanaffos. 2023 Mar;22(3):276-278.
4
Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury.
Case Rep Crit Care. 2024 Feb 22;2024:6631866. doi: 10.1155/2024/6631866. eCollection 2024.
5
Remdesivir: treatment of COVID-19 in special populations.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3829-3855. doi: 10.1007/s00210-023-02927-2. Epub 2024 Jan 5.
6
Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment.
BMC Infect Dis. 2024 Jan 2;24(1):3. doi: 10.1186/s12879-023-08859-9.
7
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
CPT Pharmacometrics Syst Pharmacol. 2023 Apr;12(4):513-521. doi: 10.1002/psp4.12936. Epub 2023 Feb 22.
8
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19.
Clin Kidney J. 2022 Aug 23;15(11):2056-2062. doi: 10.1093/ckj/sfac185. eCollection 2022 Nov.
9
Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study.
Clin Infect Pract. 2022 Nov;16:100207. doi: 10.1016/j.clinpr.2022.100207. Epub 2022 Oct 13.
10
A population pharmacokinetic model of remdesivir and its major metabolites based on published mean values from healthy subjects.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan;396(1):73-82. doi: 10.1007/s00210-022-02292-6. Epub 2022 Sep 20.
本文引用的文献
1
Remdesivir against COVID-19 and Other Viral Diseases.
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00162-20. Print 2020 Dec 16.
2
AKI in Hospitalized Patients with COVID-19.
J Am Soc Nephrol. 2021 Jan;32(1):151-160. doi: 10.1681/ASN.2020050615. Epub 2020 Sep 3.
3
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
Kidney Int. 2020 Dec;98(6):1530-1539. doi: 10.1016/j.kint.2020.07.030. Epub 2020 Aug 15.
4
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980. doi: 10.1093/jac/dkaa239.
5
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.
Clin Transl Sci. 2020 Sep;13(5):896-906. doi: 10.1111/cts.12840. Epub 2020 Aug 5.
6
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.
J Am Soc Nephrol. 2020 Jul;31(7):1384-1386. doi: 10.1681/ASN.2020050589. Epub 2020 Jun 8.
7
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19.
ACS Cent Sci. 2020 May 27;6(5):672-683. doi: 10.1021/acscentsci.0c00489. Epub 2020 May 4.
8
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
9
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
Crit Care. 2015 Feb 3;19(1):32. doi: 10.1186/s13054-015-0753-8.
10
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
J Pharm Sci. 2010 Aug;99(8):3291-301. doi: 10.1002/jps.22109.
Zotero 插件